196
Views
23
CrossRef citations to date
0
Altmetric
Retracted Article

RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study

ORCID Icon, , , , , , , ORCID Icon, , , , , , ORCID Icon, , & show all
Pages 291-295 | Received 20 Apr 2021, Accepted 29 Jun 2021, Published online: 15 Jul 2021
 

Statement of Retraction

We, the Editors and Publisher of Expert Review of Anti-Infective Therapy, have retracted the following article:

Mahmoud El-Bendary, Sherief Abd-Elsalam, Tamer Elbaz, Wafaa El-Akel, Ahmed Cordie, Tamer Elhadidy, Hatem Elalfy, Khaled Farid, Mohamed Elegezy, Adel El-Badrawy, Mustafa Neamatallah, Mohamed Abd Elghafar, Marwa Salama, Mohamed AbdAllah, Mahmoud Essam, Mostafa El-Shazly & Gamal Esmat, Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study, Expert Review of Anti-infective Therapy, Volume 20, 2022 - Issue 2, https://www.tandfonline.com/doi/full/10.1080/14787210.2021.1950532

Since publication, significant concerns have been raised about the integrity of the data and reported results in the article. When approached for an explanation, the authors have been unable to fully address the concerns raised and have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed. The authors do not agree with the retraction.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

View retraction statement:
Statement of Retraction

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.